Avai Bio, Revenue Growth Rates (AVAI), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
AVAI BIO, INC.  (OTC: AVAI)
 

AVAI's Revenue Growth by Quarter and Year

Avai Bio,'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/AVAI/growth
https://api.csimarket.com/api/v1/companies/AVAI/fundamentals
https://api.csimarket.com/api/v1/companies/AVAI/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
AVAI Revenue (in millions $) FY 2027 FY 2026 FY 2025 FY 2024
4th Quarter March -
3rd Quarter December -
2nd Quarter September 0.00
1st Quarter June -0.13
FY -0.13





AVAI Revenue second quarter 2027 Y/Y Growth Comment
AVAI BIO, INC. in the second quarter 2027 recorded of $ 0.00 millions.

According to the results reported in the second quarter 2027, Avai Bio, Inc. achieved the best Revenue growth in Cloud Computing & Data Analytics industry. While Avai Bio, Inc.' s Revenue no change of 0% ranks overall at the positon no. in the second quarter 2027.


AVAI Revenue ( Y/Y Growth %) 2027
 FY 2026 FY 2025 FY 2024
4th Quarter March -
3rd Quarter December -
2nd Quarter September -
1st Quarter June -
FY   -

Financial Statements
Avai Bio,'s second quarter 2027 Revenue $ 0.00 millions AVAI's Income Statement
Avai Bio,'s second quarter 2026 Revenue $ 0.00 millions Quarterly AVAI's Income Statement


AVAI Revenue (Quarter on Quarter Growth %)

 2027
 FY 2026 FY 2025 FY 2024
4th Quarter March -
3rd Quarter December -
2nd Quarter September -
1st Quarter June -
FY (Year on Year)   -


Back to AVAI Growth rate Comparisons >> Back to AVAI Growth rate Comparisons >>


Revenue second quarter 2027 Y/Y Growth Company Ranking
Within: No.
Cloud Computing & Data Analytics Industry #
Technology Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue second quarter 2027 Y/Y Growth Company Ranking
Within: No.
Cloud Computing & Data Analytics Industry #
Technology Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2024, 2025, 2026, 2027

Avai Bio,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AVAI's II. Quarter Q/Q Revenue Comment
Despite the fact, that AVAI BIO, INC. in the II. Quarter 2027 revealed of $ 0.00 millions, it should be mentioned, that those numbers are recovery in contrast to the -0.13 millions in the first quarter.

Within Cloud Computing & Data Analytics industry AVAI BIO, INC. achieved highest sequential Revenue growth. While Avai Bio,'s Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Cloud Computing & Data Analytics Industry #
Technology Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Cloud Computing & Data Analytics Industry #
Technology Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AVAI's II. Quarter Q/Q Revenue Comment
Despite the fact, that AVAI BIO, INC. in the II. Quarter 2027 revealed of $ 0.00 millions, it should be mentioned, that those numbers are recovery in contrast to the -0.13 millions in the first quarter.

Within Cloud Computing & Data Analytics industry AVAI BIO, INC. achieved highest sequential Revenue growth. While Avai Bio,'s Revenue growth quarter on quarter, overall rank is .


Avai Bio,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 0.00
Y / Y Revenue Growth (TTM) -
Year on Year Revenue Growth Overall Ranking #
Seqeuential Revenue Change (TTM) -
Seq. Revenue Growth (TTM) Overall Ranking #


Cumulative Revenue growth Comment
In the Jun 30 2026 period, Avai Bio,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

AVAI BIO, INC. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Cloud Computing & Data Analytics Industry #
Technology Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Jun 30 2026 period, Avai Bio,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

AVAI BIO, INC. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Cloud Computing & Data Analytics Industry #
Technology Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Cloud Computing & Data Analytics Industry Revenue Growth Trends and Statistics
Technology Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AVAI's Revenue Growth Ratio versus Cloud Computing & Data Analytics Industry, Technology Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Sep 30 2026 within Technology SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Key Tronic Corporation-0.07%$ -0.075 millions
Playtika Holding Corp -0.12%$ -0.119 millions
Cirrus Logic Inc -0.16%$ -0.163 millions
King Resources, Inc.-0.37%$ -0.375 millions
Trade Desk Inc -0.47%$ -0.469 millions
Pitney Bowes Inc-0.76%$ -0.760 millions
Universal Electronics Inc -0.78%$ -0.776 millions
Omnicell inc-0.85%$ -0.854 millions
Gartner Inc -1.27%$ -1.265 millions
Commerce com Inc -1.39%$ -1.392 millions
Marketwise Inc -1.45%$ -1.453 millions
Kyndryl Holdings Inc-1.88%$ -1.881 millions
Ncr Atleos Corporation-1.96%$ -1.963 millions
Rapid7 Inc -2.11%$ -2.107 millions
Alpha And Omega Semiconductor Limited-2.25%$ -2.249 millions
Mobileye Global inc -2.38%$ -2.381 millions
Owlet Inc -2.48%$ -2.478 millions
Expensify Inc -4.00%$ -4.003 millions
Dxc Technology Co-4.02%$ -4.018 millions
Webtoon Entertainment Inc -4.04%$ -4.038 millions
Solaredge Technologies Inc -4.15%$ -4.145 millions
Magnachip Semiconductor Corporation-4.28%$ -4.283 millions
Bio Key International Inc-4.32%$ -4.319 millions
Upland Software Inc -4.66%$ -4.662 millions
Mcgraw Hill Inc -5.52%$ -5.515 millions
T1 Energy Inc -5.83%$ -5.833 millions
Taboola com Ltd -6.81%$ -6.805 millions
Upwork Inc -7.61%$ -7.610 millions
Nve Corp-8.07%$ -8.071 millions
Qualcomm Inc-8.42%$ -8.420 millions


About Avai Bio, Revenue Growth Rates (AVAI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Avai Bio Inc (CIK 1740797).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001740797-26-000026
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Avai Bio Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.